Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by United Therapeutics Corporation < Previous 1 2 Next > United Therapeutics Corporation to Report Second Quarter 2024 Financial Results Before the Market Opens on Wednesday, July 31, 2024 July 24, 2024 From United Therapeutics Corporation Via Business Wire Tickers UTHR United Therapeutics Corporation Announces Full Enrollment of the TETON 2 Study of Inhaled Treprostinil for the Treatment of Idiopathic Pulmonary Fibrosis July 10, 2024 From United Therapeutics Corporation Via Business Wire Tickers UTHR United Therapeutics Corporation Announces Election of Jan Malcolm to its Board of Directors June 27, 2024 From United Therapeutics Corporation Via Business Wire Tickers UTHR United Therapeutics Corporation to Present at the Goldman Sachs 45th Annual Global Healthcare Conference June 05, 2024 From United Therapeutics Corporation Via Business Wire Tickers UTHR United Therapeutics Corporation Reports First Quarter 2024 Financial Results May 01, 2024 From United Therapeutics Corporation Via Business Wire Tickers UTHR CORRECTING and REPLACING PHOTO United Therapeutics Announces World’s First Successful Xenothymokidney Transplant April 26, 2024 From United Therapeutics Corporation Via Business Wire Tickers UTHR United Therapeutics Corporation to Report First Quarter 2024 Financial Results Before the Market Opens on Wednesday, May 1, 2024 April 24, 2024 From United Therapeutics Corporation Via Business Wire Tickers UTHR United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2024 International Conference April 16, 2024 From United Therapeutics Corporation Via Business Wire Tickers UTHR United Therapeutics Announces the First Comprehensive Review Publication on Xenotransplantation March 26, 2024 From United Therapeutics Corporation Via Business Wire Tickers UTHR United Therapeutics Corporation Announces $1 Billion Accelerated Share Repurchase Program March 25, 2024 From United Therapeutics Corporation Via Business Wire Tickers UTHR United Therapeutics Corporation to Present at the Leerink Partners Global Biopharma Conference 2024 March 05, 2024 From United Therapeutics Corporation Via Business Wire Tickers UTHR United Therapeutics Corporation to Present at the TD Cowen 44th Annual Health Care Conference February 27, 2024 From United Therapeutics Corporation Via Business Wire Tickers UTHR United Therapeutics Corporation Reports Fourth Quarter and Full Year 2023 Financial Results February 21, 2024 From United Therapeutics Corporation Via Business Wire Tickers UTHR United Therapeutics Commences Litigation to Ensure Fairness in the Drug Review Process February 21, 2024 From United Therapeutics Corporation Via Business Wire Tickers UTHR United Therapeutics Corporation to Present at the 42nd Annual J.P. Morgan Healthcare Conference December 29, 2023 From United Therapeutics Corporation Via Business Wire Tickers UTHR United Therapeutics and Miromatrix Medical Announce Completion of Tender Offer and Merger December 13, 2023 From United Therapeutics Corporation Via Business Wire Tickers MIRO UTHR United Therapeutics and Miromatrix Medical Announce Successful Tender Offer December 12, 2023 From United Therapeutics Corporation Via Business Wire Tickers MIRO UTHR United Therapeutics Named by Newsweek as One of America’s Most Responsible Companies 2024 December 07, 2023 From United Therapeutics Corporation Via Business Wire Tickers UTHR United Therapeutics Corporation Reports Third Quarter 2023 Financial Results November 01, 2023 From United Therapeutics Corporation Via Business Wire Tickers UTHR United Therapeutics Announces First Patient Enrolled in Phase 3 TETON PPF Study of Nebulized Tyvaso in Patients with Progressive Pulmonary Fibrosis October 31, 2023 From United Therapeutics Corporation Via Business Wire Tickers UTHR United Therapeutics Corporation to Present at the UBS Biopharma Conference 2023 October 31, 2023 From United Therapeutics Corporation Via Business Wire Tickers UTHR United Therapeutics to Acquire Miromatrix Medical October 30, 2023 From United Therapeutics Corporation Via Business Wire Tickers MIRO UTHR United Therapeutics Corporation to Report Third Quarter 2023 Financial Results Before the Market Opens on Wednesday, November 1, 2023 October 25, 2023 From United Therapeutics Corporation Via Business Wire Tickers UTHR United Therapeutics Announces Recent Milestones for its Heart and Kidney Xenotransplantation Programs September 22, 2023 From United Therapeutics Corporation Via Business Wire Tickers UTHR United Therapeutics Issues its 2023 Corporate Responsibility and Public Benefit Report September 12, 2023 From United Therapeutics Corporation Via Business Wire Tickers UTHR United Therapeutics Corporation to Present at the Morgan Stanley 21st Annual Global Healthcare Conference September 01, 2023 From United Therapeutics Corporation Via Business Wire Tickers UTHR United Therapeutics Corporation Reports Second Quarter 2023 Financial Results August 02, 2023 From United Therapeutics Corporation Via Business Wire Tickers UTHR United Therapeutics Corporation to Report Second Quarter 2023 Financial Results Before the Market Opens on Wednesday, August 2, 2023 July 26, 2023 From United Therapeutics Corporation Via Business Wire Tickers UTHR United Therapeutics Wins Appeal in Dry Powder Inhaler Patent Litigation July 24, 2023 From United Therapeutics Corporation Via Business Wire Tickers UTHR United Therapeutics Unveils Net Zero Energy Distribution Center June 14, 2023 From United Therapeutics Corporation Via Business Wire Tickers UTHR < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.